NEW YORK (GenomeWeb) – Premaitha Health is providing noninvasive prenatal testing services to Servicios Genéticos OriGen, a private laboratory group in Santiago, Chile, the company said today.

Under the agreement, OriGen will send maternal blood samples to Premaitha's clinical laboratory in Manchester, UK, which will analyze them using the firm's Iona test, which estimates the fetal risk for trisomies 21, 18, and 13. Following the testing process, which takes three days, Premaitha will send the test results to OriGen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.